fludarabine has been researched along with Hepatitis B in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castellano, G; Dominguez, N; Fernandez, I; Manzano, ML; Martin, A; Muñoz, R | 1 |
| Hasegawa, K; Hirayama, Y; Ishihara, T; Kanagawa, M; Koyama, J; Suzuki, T; Terui, T | 1 |
| Buti, M; Esteban, R; Homs, M; Palacios, A; Rodriguez-Frias, F; Sanchez, MJ | 1 |
| Allain, JP; Candotti, D; El Chaar, M; Power, JP; Spillane, D; Temple, J; Thomas, M | 1 |
| Capoluongo, N; Coppola, N; Fiore, M; Guastafierro, S; Iodice, V; Messina, V; Pasquale, G; Pisaturo, M; Sagnelli, C; Sagnelli, E; Stanzione, M; Tonziello, G | 1 |
| Arase, Y; Hamaki, T; Hayashi, M; Igarashi, M; Ishibashi, T; Kami, M; Kusumi, E; Miyakoshi, S; Morinaga, S; Mutou, Y; Shimamura, K; Takaue, Y | 1 |
| Disel, U; Paydas, S; Sahin, B; Yavuz, S | 1 |
| Ciancia, R; De Divitiis, B; De Renzo, A; Del Giudice, A; Pane, F; Persico, M; Picardi, M; Quintarelli, C; Rotoli, B; Salvatore, F | 1 |
| Smolej, L | 1 |
| Alexopoulou, A; Archimandritis, AJ; Dourakis, SP; Karayiannis, P; Pandelidaki, H | 1 |
| Kim, HS; Niihara, Y; Yospur, L | 1 |
| Bruzzone, BM; Cataldi, A; Franceschini, R; Icardi, G; Tenconi, GL | 1 |
1 review(s) available for fludarabine and Hepatitis B
| Article | Year |
|---|---|
Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mutation; Recurrence; Rituximab; Vidarabine | 2009 |
11 other study(ies) available for fludarabine and Hepatitis B
| Article | Year |
|---|---|
Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hepatitis B; Hepatitis B virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Rituximab; Time Factors; Vidarabine; Virus Activation | 2015 |
B-cell lymphoma developing de novo hepatitis B after salvage therapies including rituximab through seroconversion of surface antibody.
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Lymphoma, B-Cell; Prednisone; Recurrence; Remission Induction; Risk; Rituximab; Salvage Therapy; Vidarabine; Vincristine; Virus Activation | 2014 |
HBV reactivation after fludarabine chemotherapy identified on investigation of suspected transfusion-transmitted Hepatitis B virus.
Topics: Antineoplastic Agents; Blood Transfusion; Disease Transmission, Infectious; Hepatitis B; Hepatitis B virus; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine; Virus Activation | 2010 |
Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antiviral Agents; DNA, Viral; Female; Hepatitis B; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Rituximab; Survival Analysis; Vidarabine; Viral Load; Viremia; Virus Activation | 2011 |
Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Hematopoietic Stem Cell Transplantation; Hepatitis B; Humans; Liver Cirrhosis; Lymphoma, T-Cell; Male; Middle Aged; Time Factors; Vidarabine | 2003 |
Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Agents; DNA (Cytosine-5-)-Methyltransferases; DNA, Viral; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Vidarabine; Virus Activation | 2003 |
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carrier State; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Antigens; Hepatitis B virus; Hepatitis C Antibodies; Humans; Lamivudine; Liver Failure; Lymphoma, Non-Hodgkin; Male; Middle Aged; Sequence Homology; Vidarabine; Virus Activation | 2003 |
Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
Topics: Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Hepatitis B; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Rituximab; Treatment Outcome; Vidarabine | 2007 |
Detection of a hepatitis B surface antigen variant emerging in a patient with chronic lymphocytic leukaemia treated with fludarabine.
Topics: Aged; Amino Acid Sequence; Antineoplastic Agents; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Mutation; Phylogeny; Vidarabine | 2006 |
Chronic lymphocytic leukemia in a patient with sickle cell anemia.
Topics: Anemia, Sickle Cell; Antineoplastic Agents; Chronic Disease; Fatal Outcome; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine | 1998 |
Reactivation of hepatitis B virus infection during cytotoxic chemotherapy.
Topics: Acute Disease; Aged; Antineoplastic Agents; Hepatitis B; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Vidarabine | 2001 |